Genedant logo

Genedant

Asia, Central Region, Singapore, Singapore

Description

Genedant invests in emerging life science and technology which challenge the conventional thinking of what is possible.

Investor Profile

Genedant has made 3 investments, with 1 in the past 12 months and 67% as lead.

Stage Focus

  • Pre Seed (67%)
  • Seed (33%)

Country Focus

  • Singapore (33%)
  • United Kingdom (33%)
  • United States (33%)

Industry Focus

  • Food And Beverage
  • Food Processing
  • Innovation Management
  • Machine Learning
  • Manufacturing
  • Seafood
  • Beauty
  • Health Care
  • Health Diagnostics
  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Genedant frequently co-invest with?

SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 2
Cult Food Science
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
Venture for America
North America, New York, United States, New York
Co-Investments: 1
Impact Venture Capital
North America, California, United States, Burlingame
Co-Investments: 1
Plug and Play
North America, California, United States, Sunnyvale
Co-Investments: 1
Better Bite Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Katapult Ocean
Europe, Oslo, Norway, Oslo
Co-Investments: 1
Metaplanet
Europe, Harjumaa, Estonia, Tallinn
Co-Investments: 1
Prithvi Ventures
North America, New York, United States, New York
Co-Investments: 1
Plug and Play Asia Pacific
Asia, Central Region, Singapore, Singapore
Co-Investments: 1

Which angels does Genedant often collaborate with?

BH
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Genedant?

Rybodyn

San Diego, California, United States

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

BiotechnologyMedicalPharmaceuticalTherapeutics
Pre SeedJan 9, 2025
Amount Raised: $4,000,000
UMAMI Bioworks

Singapore, Central Region, Singapore

UMAMI Bioworks is building the development and production platform for seafood that is cultivated, not caught.

Food and BeverageFood ProcessingInnovation ManagementMachine LearningManufacturingSeafood
Pre SeedMar 2, 2022
Amount Raised: $2,400,000
Sequential

London, England, United Kingdom

The Skin Microbiome Testing Co.

BeautyHealth CareHealth Diagnostics
SeedOct 10, 2021
Amount Raised: $1,650,000